Overview
Status
Active
Registry date
2013-04-26
Share capital
125,000.00 PLN
Registered address
Białobrzeska 45, 41-409 Mysłowice, Poland
Electronic delivery address
AE:PL-21547-23571-TSGAB-28
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 9 days late).
- 202524/07/2026
- 202410/07/2025
- 202321/06/2024
- 202221/06/2023
- 202106/07/2022
- 202008/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.57mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 75.34kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 1.48mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 291.72kMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Ipharm 4 has been an NFZ healthcare provider since 2023. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | śląskie | 1 | USD 0.00 |
Authorized Representatives
Adam Marcin Pecyna – Attorney-in-fact (sole)
Anna Palka Porwit – Attorney-in-fact (sole)
Aleksander Porwit – President of the Management Board
Manner of representation
The company is represented by each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,275 | $17,220.42 | 51% | |
Aleksander Porwitage 50 | 1,225 | $16,545.11 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-03-01.
45 1140 1049 0000 7214 3800 1001
58 1050 1214 1000 0090 3082 8850
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $44,139.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,805$2,805 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,352$2,352 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 26, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $36,572$36,572 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $18,905,980.22 | managementcompany.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-03-16 | PKD change (Removed: 7 codes) | |
| 2014-05-08 | Share capital increase (5,000.00 PLN → 125,000.00 PLN) | |
| 2013-04-26 | Entered in the register |
FAQ
The main business activity of Ipharm 4 focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on April 26, 2013.
The headquarters is located at: Białobrzeska 45, 41-409 Mysłowice.
The share capital of the company is PLN 125,000 (approx. $33,766).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $1,566,987, representing an increase of 10.4% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $75,343, meaning the company increased its profit by 984.4%.
The largest operating cost category falls under other operating costs. This category amounted to $1,314,647 in 2025, representing 89% of all operating expenses.
Last updated: 2026-07-24